Warfarin therapeutic monitoring: Is 70% time in the therapeutic range the best we can do?

Journal of Clinical Pharmacy and Therapeutics

Volumn 37, Issue 4, 2012, Pages 375-377

  Lader, E ^a,b   Martin, N ^a   Cohen, G ^a   Meyer, M ^a   Reiter, P ^a   Dimova, A ^a   Parikh, D ^a  

^a Mid Valley Cardiology   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

anticoagulation; international normalized ratio; outcomes and process assessment; warfarin

Indexed keywords

WARFARIN;

ALGORITHM; ANTICOAGULANT THERAPY; DRUG EFFICACY; DRUG MONITORING; GENETIC POLYMORPHISM; HUMAN; INTERNATIONAL NORMALIZED RATIO; PATIENT COMPLIANCE; PRESCRIPTION; REVIEW; STEADY STATE;

ANTICOAGULANTS; DRUG MONITORING; HUMANS; INTERNATIONAL NORMALIZED RATIO; TIME FACTORS; WARFARIN;

EID: 84860796230     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2011.01324.x     Document Type: Review

References (19)

1. Emmett CN, Moon RY, Vanderveer JB,. Clinical evaluation of a new oral anticoagulant "Sintrom". Circulation 1957; 15: 713-720.
2. Hirsh J, Dalen JE, Deykin D, Poller L, Bussey H,. Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest 1995; 108: 231S-246S.
3. Aithal GP, Day CP, Kesteven PJ, Daly AK,. Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications. Lancet 1999; 353: 717-719. (Pubitemid 29103806)
4. Connolly SJ, Pogue J, Eikelboom J, et al. Benefit of oral anticoagulation over antiplatelet therapy in atrial fibrillation depends on the quality of International Normalized Ratio control achieved by centers and countries as measured by Time in Therapeutic Range. Circulation 2008; 118: 2029-2037.
5. Cortelazzo S, Finazzi G, Viero P, Galli M, Remuzzi A, Parenzan L, Barbui T,. Thrombotic and hemorrhagic complications in patients with mechanical heart valve prosthesis attending an anticoagulation clinic. Thromb Haemost 1993; 69: 316-320. (Pubitemid 23103115)
6. Chiquette E, Amato MG, Bussey HI,. Comparison of an anticoagulation clinic with usual medical care. Arch Int Med 1998; 158: 1641-1647.
7. Wilson SJ, Wells PS, Kovacs MJ, Lewis GM, Martin J, Burton E, Anderson DR,. Comparing the quality of oral anticoagulant management by anticoagulation clinics and by family physicians: a randomized controlled trial. CMAJ 2003; 169: 293-298. (Pubitemid 37047057)
8. Witt DM, Sadler MA, Shanahan RL, Mazzoli G, Tillman DJ,. Effect of a centralized clinical pharmacology anticoagulation service on the outcomes of anticoagulation therapy. Chest 2005; 127: 1515-1522. (Pubitemid 46218774)
9. Poli D, Antonucci E, Testa S, Tosetto A, Ageno W, Palareti G,. Bleeding risk in very old patients on Vitamin K antagonist treatment. Circulation 2011; 124: 824-829.
10. Oversen L, Lyduch S, Ott P,. A simple technique for predicting maintenance dosage of warfarin-is it better than empirical dosing? Eur J Clin Pharmacol 1989; 37: 573-576. (Pubitemid 20025771)
11. Sconce EA, Khan TI, Wynne HA, et al. The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements: proposal for a new dosing regimen. Blood 2005; 106: 2329-2333. (Pubitemid 41510803)
12. Poller L, Wright D, Rowlands M,. Prospective comparative study of computer programs used for management of warfarin. J Clin Pathol 1993; 46: 299-303. (Pubitemid 23138740)
13. Bloomfield HE, Krause A, Greer N, et al. Meta-analysis: effect of patient self-testing and self-management of long-term anticoagulation on major clinical outcomes. Ann Int Med 2011; 154: 472-482.
14. Heneghan C, Alonso-Coello P, Garcia-Alamino M, Perera R, Meats E, Glasziou P,. Self-monitoring of oral anticoagulation: a systematic review and meta-analysis. Lancet 2006; 367: 404-411. (Pubitemid 43184260)
15. Self-monitoring for patients on warfarin? Drug Ther Bull 2009; 47: 98-101.
16. Kimmel SE,. Warfarin therapy: in need of improvement after all these years. Expert Opin Pharmacother 2008; 9: 677-686. (Pubitemid 351566188)
17. Finkelman BS, Gage BF, Johnson JA, Brensinger CM, Kimmel SE,. Genetic warfarin dosing: tables versus algorithms. J Am Coll Cardiol 2011; 57: 612-618.
18. Lader E, Martin N, Reiter P, Cohen G, Dimova A, Parikh D,. Quality improvement strategy for better control of warfarin anticoagulation in outpatients. Presented at Quality of Care and Outcomes in Cardiovascular Disease and Stroke 2011 Scientific Sessions; May 19-21, 2010; Washington, DC
19. Food and Drug Administration Draft Briefing Document for the Cardiovascular and Renal Drugs Advisory Committee. September 8, 2011.